Zobrazeno 1 - 10
of 465
pro vyhledávání: '"JUNNIAN ZHENG"'
Autor:
Ning Feng, Rui Zhang, Xin Wen, Wei Wang, Nie Zhang, Junnian Zheng, Longzhen Zhang, Nianli Liu
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-10 (2024)
Abstract The RAB interacting factor (RABIF) is a putative guanine nucleotide exchange factor that also functions as a RAB-stabilizing holdase chaperone. It has been implicated in pathogenesis of several cancers. However, the functional role and molec
Externí odkaz:
https://doaj.org/article/95f179aa86df49a6881e27e80c70bc71
Autor:
Wei Zhang, Dan Liu, Tao Zhang, Jiang Cao, Gang Wang, Huizhong Li, Su Zhou, Ruixue Zhang, Yuqiao Wang, Jinyu Li, Zixuan Zhang, Hao Chen, Yong Zhang, Shenyang Zhang, Jie Zu, Xiaopeng Wang, Chuanying Xu, Manli Zhou, Ming Shi, Guiyun Cui, Junnian Zheng
Publikováno v:
hLife, Vol 2, Iss 8, Pp 434-438 (2024)
Externí odkaz:
https://doaj.org/article/fdf4404f542d4e5fbce99d948c9a4368
Autor:
Zhiying Shao, Hao Yan, Min Zhu, Zhengyang Liu, Ziqin Chen, Weiqi Li, Chenyang Wang, Longzhen Zhang, Junnian Zheng
Publikováno v:
Heliyon, Vol 10, Iss 23, Pp e40558- (2024)
Purpose: The prognosis of isocitrate dehydrogenase (IDH) wild-type glioblastoma (GBM) with the subventricular zone (SVZ) invasion is extremely unfavorable but the underlying mechanism remains unclear. We aimed to conduct a retrospective study to main
Externí odkaz:
https://doaj.org/article/9c1cd31d6d6d40af8ec381093c1d6bf5
Autor:
Yuxin Chen, Meng Wang, Shuxin Huang, Lulu Han, Ying Cai, Xiaodi Xu, Shuwen Sun, Zhaokai Chen, Junze Chen, Jiatian Yu, Hongwei Du, Huizhong Li, Junnian Zheng, Bo Ma, Gang Wang
Publikováno v:
Pharmacological Research, Vol 210, Iss , Pp 107506- (2024)
Lack of biopsies after treatment, especially in solid tumors, restricts the understanding of chimeric antigen receptor (CAR)-T cells -related characteristic in vivo, thus hindering the development of strategies to improve CAR-T cells efficacy. Here,
Externí odkaz:
https://doaj.org/article/4238c5ac3c264d908351730d6829f867
Autor:
Miaomiao Zhang, Haiting Wang, Meng Wang, Haoliang Zhang, Huizhong Li, Ping Ma, Junnian Zheng, Gang Wang, Shibao Li
Publikováno v:
Translational Oncology, Vol 50, Iss , Pp 102111- (2024)
Erythropoietin-producing hepatocyte receptor A2 (EphA2) is an attractive target for immunotherapy due to its high expression in a variety of solid tumors including prostate cancer. Among various types of immunotherapeutics, chimeric antigen receptor
Externí odkaz:
https://doaj.org/article/4ff26f59569d47aca5f919e3fc19701f
Autor:
Ming Shi, Jiaojiao Wang, Hongming Huang, Dan Liu, Hai Cheng, Xu Wang, Wei Chen, Zhiling Yan, Wei Sang, Kunming Qi, Depeng Li, Feng Zhu, Zhenyu Li, Jianlin Qiao, Qingyun Wu, Lingyu Zeng, Xiaoming Fei, Weiying Gu, Yuqing Miao, Kailin Xu, Junnian Zheng, Jiang Cao
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Despite the high therapeutic response achieved with B-cell maturation antigen (BCMA)-specific chimeric antigen receptor (CAR) T-cell therapy in relapsed and refractory multiple myeloma (R/R MM), primary resistance and relapse exist with sing
Externí odkaz:
https://doaj.org/article/747a7911739249cd91c5dcffffc31488
Autor:
Zheng Lu, Gang Wang, Junnian Zheng, Lin Fang, Fei Zhu, Wenjing Tang, Guangya Zhao, Yingxiang Shao, Bowen Lu, Jiage Ding, Yanyan Zheng, Huizhong Li, Renjin Chen, Dafei Chai
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 8 (2024)
Background Targeting kinases presents a potential strategy for treating solid tumors; however, the therapeutic potential of vaccines targeting kinases remains uncertain.Methods Adenovirus (Ad) vaccines encoding Aurora kinase A (AURKA) or cyclin-depen
Externí odkaz:
https://doaj.org/article/5fe9b37062a84aa0a9b5e87779733f13
Autor:
Zhigang Shen, Tao Dong, Hongmei Yong, Chuyin Deng, Changxiu Chen, Xintian Chen, Miaolei Chen, Sufang Chu, Junnian Zheng, Zhongwei Li, Jin Bai
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-13 (2024)
Abstract Glioblastoma (GBM) is the most common malignant primary brain tumor. Despite comprehensive treatment with traditional surgery, radiotherapy, and chemotherapy, the median survival rate is
Externí odkaz:
https://doaj.org/article/d0ed42672d7844e689e131e2935966d6
Autor:
Yan Wang, Yihao Wang, Chunjie Wu, Yunfei Ji, Pingfu Hou, Xueqing Wu, Zhongwei Li, Minle Li, Sufang Chu, Qianqian Ning, Bo Xu, Junnian Zheng, Jin Bai
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-15 (2024)
Abstract The metastasis of non-small cell lung cancer (NSCLC) is the leading death cause of NSCLC patients, which requires new biomarkers for precise diagnosis and treatment. Circular RNAs (circRNAs), the novel noncoding RNA, participate in the progr
Externí odkaz:
https://doaj.org/article/a30998d7c9d2448f802dae2129c0da6b
Autor:
Dameng Li, Xueying Zhou, Wenxian Xu, Yongxin Cai, Chenglong Mu, Xinchun Zhao, Tingting Tang, Chen Liang, Tao Yang, Junnian Zheng, Liang Wei, Bo Ma
Publikováno v:
Cancer & Metabolism, Vol 12, Iss 1, Pp 1-11 (2024)
Abstract Background Metastasis is the leading cause of death among prostate cancer (PCa) patients. Obesity is associated with both PCa-specific and all-cause mortality. High-fat diet (HFD) is a risk factor contributing to obesity. However, the associ
Externí odkaz:
https://doaj.org/article/beb4836389bd48a9a43c4a886d9b0d4c